Dr. Yim Cheuk Wan - Rheumatology
Specialist in Rheumatology
Highlights
- MCHK RegisteredVerified
- Specialist in RheumatologyBachelor of Medicine and Bachelor of Surgery (MBChB) · Hong Kong College of Physicians · Medical degree 1994
- InsuranceBeing compiled｜See details
About
Dr. Yim Cheuk Wan is a registered Rheumatology specialist in Hong Kong.
Education
Specialist in Rheumatology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)1994
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Yim Cheuk Wan? Claim page and update insurance →
Hospital Affiliations
Referrals available to these hospitals
FAQ
Is Dr. Yim Cheuk Wan any good?
Dr. Yim Cheuk Wan is a registered Rheumatology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Yim Cheuk Wan do?
Dr. Yim Cheuk Wan practises in Rheumatology.
Are you Dr. Yim Cheuk Wan? Claim this page to update and manage.
ClaimResearch and publications
9 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry.Rheumatology (Oxford, England) · 2024
- Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.Rheumatology (Oxford, England) · 2023
- Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2021
- Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial.Annals of the rheumatic diseases · 2021
- DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.Annals of the rheumatic diseases · 2020
- Hyperuricemia in Asian psoriatic arthritis patients.International journal of rheumatic diseases · 2018
- Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.ERJ open research · 2018
- Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.Annals of the rheumatic diseases · 2016
- IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.Seminars in arthritis and rheumatism · 2015
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer